Peter Dicpinigaitis, MD, professor of medicine at the Albert Einstein College of Medicine and director of the Montefiore Cough Center, discusses what he and others have seen during the pandemic in patients with chronic cough who had COVID-19.
Peter Dicpinigaitis, MD, professor of medicine at the Albert Einstein College of Medicine and director of the Montefiore Cough Center, discusses what he and others have seen during the pandemic in patients with chronic cough who had COVID-19.
Transcript
Has COVID-19 impacted the cough field? Are more patients presenting with cough or does the virus exacerbate it?
The COVID question is a fascinating one. I work mainly in intensive care units. So I was on the front lines in the very beginning in the spring of 2020. And way back then, those of us that deal with cough a lot, were wondering whether there was going to be a post-COVID chronic cough, because those of us who see chronic cough patients in general, we see a lot of chronic cough that began with a typical viral upper respiratory tract infection or common cold, that's very common, that you know, somebody has a cold, they're sick for 3 or 4 days, the cold goes away, but a cough can linger for weeks, months or years. So we see post-viral cough all the time. So the question was, well, will COVID-19 be similar to that, less of a problem, or a problem? Interestingly, in retrospect, now that we have enough time behind us to look at what the symptoms are in patients who were sick with COVID, especially those serious enough to be hospitalized. Interestingly, post-COVID cough does not seem to be a major issue. About 1 in 6 patients who are seen in clinics after hospitalization out to severe illness complain of have some degree of cough, usually not severe. Interestingly, it's much more common for these patients to complain of shortness of breath, chest tightness and fatigue than chronic cough. So yes, the chronic coughers are out there, but thankfully, COVID-19 seems to not be a virus that specifically induced a lot of severe prolonged cough.
Review Emphasizes Potential Infection Risks With BTK Inhibitors
November 2nd 2024Although Bruton tyrosine kinase (BTK) inhibitor monotherapy in chronic lymphocytic leukemia (CLL) has been a game-changer, patients have significantly increased risks of infection, especially in the upper respiratory tract.
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
PAH Treatment Outcomes Similar Regardless of Diagnosis Time
November 1st 2024The study findings underscore the importance of early initiation of macitentan and tadalafil among patients who have pulmonary arterial hypertension (PAH), and represent a shift in understanding of prognosis based on diagnosis timing.
Read More